These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1384214)

  • 1. Galanin and galanin antagonists: molecular and biochemical perspectives.
    Bartfai T; Fisone G; Langel U
    Trends Pharmacol Sci; 1992 Aug; 13(8):312-7. PubMed ID: 1384214
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Galanin--a neuroendocrine peptide.
    Bartfai T; Hökfelt T; Langel U
    Crit Rev Neurobiol; 1993; 7(3-4):229-74. PubMed ID: 7693357
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Galanin--10 years with a neuroendocrine peptide.
    Bedecs K; Berthold M; Bartfai T
    Int J Biochem Cell Biol; 1995 Apr; 27(4):337-49. PubMed ID: 7540497
    [TBL] [Abstract][Full Text] [Related]  

  • 4. N-terminal galanin fragments inhibit the hippocampal release of acetylcholine in vivo.
    Girotti P; Bertorelli R; Fisone G; Land T; Langel U; Consolo S; Bartfai T
    Brain Res; 1993 May; 612(1-2):258-62. PubMed ID: 7687191
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The novel high-affinity antagonist, galantide, blocks the galanin-mediated inhibition of glucose-induced insulin secretion.
    Lindskog S; Ahrén B; Land T; Langel U; Bartfai T
    Eur J Pharmacol; 1992 Jan; 210(2):183-8. PubMed ID: 1376272
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Biological activities of two endogenously occurring N-terminally extended forms of galanin in the rat spinal cord.
    Bedecs K; Langel U; Xu XJ; Wiesenfeld-Hallin Z; Bartfai T
    Eur J Pharmacol; 1994 Jul; 259(2):151-6. PubMed ID: 7525314
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Structure-function studies of galanin].
    Yanaihara N; Mochizuki T; Ohshima K; Iguchi K; Takatsuka N; Sato K; Hoshino M; Yanaihara C; Kuwahara A
    Nihon Naibunpi Gakkai Zasshi; 1992 Jul; 68(7):637-57. PubMed ID: 1381324
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for a role of the neuropeptide galanin in spatial learning.
    Ogren SO; Hökfelt T; Kask K; Langel U; Bartfai T
    Neuroscience; 1992 Nov; 51(1):1-5. PubMed ID: 1281521
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galanin receptors: involvement in feeding, pain, depression and Alzheimer's disease.
    Kask K; Berthold M; Bartfai T
    Life Sci; 1997; 60(18):1523-33. PubMed ID: 9126874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of adenylate cyclase activity by galanin in rat insulinoma cells is mediated by the G-protein Gi3.
    de Mazancourt P; Goldsmith PK; Weinstein LS
    Biochem J; 1994 Oct; 303 ( Pt 2)(Pt 2):369-75. PubMed ID: 7526840
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Galanin stimulates striatal acetylcholine release via a mechanism unrelated to cholinergic receptor stimulation.
    Pramanik A; Ogren SO
    Regul Pept; 1993 Jun; 45(3):353-62. PubMed ID: 7688904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New high affinity peptide antagonists to the spinal galanin receptor.
    Xu XJ; Wiesenfeld-Hallin Z; Langel U; Bedecs K; Bartfai T
    Br J Pharmacol; 1995 Oct; 116(3):2076-80. PubMed ID: 8640348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Galanin-receptor ligand M40 peptide distinguishes between putative galanin-receptor subtypes.
    Bartfai T; Langel U; Bedecs K; Andell S; Land T; Gregersen S; Ahrén B; Girotti P; Consolo S; Corwin R
    Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11287-91. PubMed ID: 7504301
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Minireview. Galanin-acetylcholine interactions: relevance to memory and Alzheimer's disease.
    Crawley JN
    Life Sci; 1996; 58(24):2185-99. PubMed ID: 8649205
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Linear and cyclic N-terminal galanin fragments and analogs as ligands at the hypothalamic galanin receptor.
    Land T; Langel U; Löw M; Berthold M; Undén A; Bartfai T
    Int J Pept Protein Res; 1991 Sep; 38(3):267-72. PubMed ID: 1722197
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Blockade of galanin-induced inhibition of insulin secretion from isolated mouse islets by the non-methionine containing antagonist M35.
    Gregersen S; Lindskog S; Land T; Langel U; Bartfai T; Ahrén B
    Eur J Pharmacol; 1993 Feb; 232(1):35-9. PubMed ID: 7681407
    [TBL] [Abstract][Full Text] [Related]  

  • 17. M-15: high-affinity chimeric peptide that blocks the neuronal actions of galanin in the hippocampus, locus coeruleus, and spinal cord.
    Bartfai T; Bedecs K; Land T; Langel U; Bertorelli R; Girotti P; Consolo S; Xu XJ; Wiesenfeld-Hallin Z; Nilsson S
    Proc Natl Acad Sci U S A; 1991 Dec; 88(23):10961-5. PubMed ID: 1720557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Galanin: a new biologically active gastrointestinal neuropeptide].
    Bauer FE
    Z Gastroenterol; 1990 Mar; 28(3):160-9. PubMed ID: 1693024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional effects and ligand binding of chimeric galanin-neuropeptide Y (NPY) peptides on NPY and galanin receptor types.
    Kahl U; Langel U; Bartfai T; Grundemar L
    Br J Pharmacol; 1994 Apr; 111(4):1129-34. PubMed ID: 7518295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Galanin: a biologically active peptide.
    Vrontakis ME
    Curr Drug Targets CNS Neurol Disord; 2002 Dec; 1(6):531-41. PubMed ID: 12769595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.